Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - academic.oup.com
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
被引用次数：290 相关文章

[引用][C] Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - repositorio.usp.br
ReP USP - Detalhe do registro: Locus coeruleus imaging as a biomarker for noradrenergic
dysfunction in neurodegenerative diseases Home About USP Schools USP Schools Escola …
[HTML] nih.gov

[HTML][HTML] Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - ncbi.nlm.nih.gov
The number of individuals over the age of 60 years is projected to rise from 841 million in
2013 to over 2 billion by 2050 (World Population Ageing report, United Nations). As the …

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain - discovery.ucl.ac.uk
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
[PDF] semanticscholar.org

[PDF][PDF] Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - …, 2019 - pdfs.semanticscholar.org
The number of individuals over the age of 60 years is projected to rise from 841 million in
2013 to over 2 billion by 2050 (World Population Ageing report, United Nations). As the …
[PDF] usp.br

[PDF][PDF] Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ BETTS, E KIRILINA, MCG OTADUY, D IVANOV… - Brain, 2019 - observatorio.fm.usp.br
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - dare.uva.nl
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain: a Journal of …, 2019 - europepmc.org
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …
[PDF] ovgu.de

[PDF][PDF] Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - 2019 - iknd.med.ovgu.de
The number of individuals over the age of 60 years is projected to rise from 841 million in
2013 to over 2 billion by 2050 (World Population Ageing report, United Nations). As the …
[PDF] oup.com

[PDF][PDF] Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - 2019 - academic.oup.com
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …